Literature DB >> 13342367

Differences in the agglutinability of human red cells by the high-titre cold antibodies of acquired haemolytic anaemia.

J H CROOKSTON, J V DACIE, V ROSSI.   

Abstract

Entities:  

Keywords:  ANEMIA, HEMOLYTIC/immunology; ANTIGENS AND ANTIBODIES

Mesh:

Substances:

Year:  1956        PMID: 13342367     DOI: 10.1111/j.1365-2141.1956.tb06705.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Acute haemolytic anaemia complicating primary atypical pneumonia.

Authors:  J T HUGHES; P C MALLAM
Journal:  Postgrad Med J       Date:  1960-06       Impact factor: 2.401

2.  [Blood group specific antierythrocyte autoantibodies].

Authors:  H C MEULI
Journal:  Blut       Date:  1957-09

3.  Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.

Authors:  R S Evans; E Turner; M Bingham
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

4.  Quantitative and thermodynamic measurements on I and i antigens of human red blood cells.

Authors:  C Doinel; C Ropars; C Salmon
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

5.  Antibody of blood-group specificity in simple ("cold") haemolytic anaemias.

Authors:  W WEINER; N K SHINTON; I R GRAY
Journal:  J Clin Pathol       Date:  1960-05       Impact factor: 3.411

6.  Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes.

Authors:  R E Mandrell; J M Griffiss; B A Macher
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

7.  THE ACTION OF ENZYMES FROM CLOSTRIDIUM TERTIUM ON THE I ANTIGENIC DETERMINANT OF HUMAN ERYTHROCYTES.

Authors:  D M MARCUS; E A KABAT; R E ROSENFIELD
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.